ARCHIVES

FDA Committee Okays Carboplatin For Second Line Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 15 No. 01 | January 6, 1989

Download PDF Visit The Full Archive

Related Articles

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

September 28, 1979

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

NCI Study Tests Donor T Cells Against Breast Cancer

August 29, 2003

In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards

July 13, 1990

In Brief: Trials Find DiBella Treatment Ineffective; Wistar Wins $1 Million Grant For Recruitment

December 4, 1998

First CCOP 3 Returns In; Payline Not Yet Determined; Goes to NCAB On Jan. 30

January 26, 1990